glp-1-based treatments approved for weight loss 2025 GLP-1 Therapy Part 1: Setting Realistic Expectations – Sarah Hormachea Blockbuster GLP-1 Diabetes and Weight
Description
While everyone's digestive system is different, persistent constipation warrants medical attention

Gene ontology and KEGG enrichment analyses were implemented for the DEGs by the GOseq R package and KOBAS software

Through our comprehensive biomarker blood testing services, users can track over 50+ internal markers including testosterone, estrogen, IGF-1, cortisol, liver and kidney function, metabolic health, inflammation levels, and more

Critics of GLP-1 therapies often portray those who use these medications as opting for an easy way out to achieve thinness, perpetuating longstanding biases like those historically associated with bariatric surgery (Heitmann, 2025)

Shortages and expiry date of medicines and stringent regulatory requirements are key limiting factors driving the market

The research team is now working to launch a prospective, multi-site clinical trial that will examine whether GLP-1 medications can reduce breast cancer incidence in females at elevated risk, including breast cancer survivors
